German Pharmaceuticals & Biotech Potentially Undervalued Companies

WuXi AppTec

Market Cap: €312.5b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

Catalyst Pharmaceuticals

Market Cap: €2.5b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

CorMedix

Market Cap: €868.0m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Agios Pharmaceuticals

Market Cap: €2.1b

A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.

Oncodesign Precision Medicine Société anonyme

Market Cap: €11.8m

A biopharmaceutical company, engages in the precision medicine business.

Amphastar Pharmaceuticals

Market Cap: €1.3b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Fennec Pharmaceuticals

Market Cap: €241.3m

Operates as a commercial stage biopharmaceutical company in the United States.

Avantor

Market Cap: €8.5b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Jazz Pharmaceuticals

Market Cap: €7.9b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Organon

Market Cap: €5.4b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

BioMarin Pharmaceutical

Market Cap: €10.4b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

ICON

Market Cap: €13.6b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Organon

Market Cap: €2.7b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Shionogi

Market Cap: €2.3t

Researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices.

hVIVO

Market Cap: €66.3m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Adocia

Market Cap: €29.6m

A clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases.

Ono Pharmaceutical

Market Cap: €802.1b

Engages in production, purchase, and sale of pharmaceuticals and diagnostic reagents worldwide.

Vistin Pharma

Market Cap: €1.0b

Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.

Cybin

Market Cap: €141.6m

A clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

Immunocore Holdings

Market Cap: €1.7b

A commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.

SCHOTT Pharma KGaA

Market Cap: €3.3b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.

Trulieve Cannabis

Market Cap: €1.8b

Operates as a cannabis retailer.

CSL

Market Cap: €96.0b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

NanoSphere Health Sciences

Market Cap: €256.9k

A nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.

Valneva

Market Cap: €732.9m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Amicus Therapeutics

Market Cap: €2.5b

A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.

Aspen Pharmacare Holdings

Market Cap: €44.9b

Manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.

HUTCHMED (China)

Market Cap: €2.3b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Sarepta Therapeutics

Market Cap: €1.7b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Navamedic

Market Cap: €370.9m

A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.

Eurofins Scientific

Market Cap: €11.1b

Provides various analytical testing and laboratory services worldwide.

Lifecore Biomedical

Market Cap: €288.0m

Operates as an integrated contract development and manufacturing organization in the United States.

SCHOTT Pharma KGaA

Market Cap: €3.3b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.

Revvity

Market Cap: €9.9b

Provides health sciences solutions, technologies, and services.

ACADIA Pharmaceuticals

Market Cap: €4.1b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

TILT Holdings

Market Cap: €2.0m

Provides various cannabis products and services in the United States, Canada, and internationally.